Cigarette smoking and disease activity in systemic lupus erythematosus

Journal of Rheumatology

Volumn 30, Issue 6, 2003, Pages 1215-1221

  Ghaussy, Najeeb O ^b   Sibbitt Jr , Wilmer L ^a   Bankhurst, Arthur D ^b   Qualls, Clifford R ^b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

Alcohol; Disease Activity; Epidemiology; Injury Cigarette Smoking; Systemic Lupus Erythematosus; Tobacco

Indexed keywords

HYDROXYCHLOROQUINE;

ADULT; AGE; ALCOHOL CONSUMPTION; ANALYSIS OF VARIANCE; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE SEVERITY; EDUCATION; ETHNOLOGY; FEMALE; HUMAN; INCOME; INTERVIEW; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; NEUROLOGIC DISEASE; ONSET AGE; ORGAN INJURY; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; TOBACCO;

ADULT; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; PREVALENCE; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 0037981295     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Pisetsky DS. Systemic lupus erythematosus: epidemiology, pathology, and pathogenesis. In: Klippel JH, editor. Primer on the rheumatic diseases. 11th ed. Atlanta: Arthritis Foundation; 1997:246-50.
2. Davis P, Percy JS. Effect of ultraviolet light on disease characteristics of NZB/W mice. J Rheumatol 1978;5:125-8.
3. Ward MM, Studenski S. Clinical prognostic factors in lupus nephritis. Arch Intern Med 1992;152:2082-8.
4. McAlindon T, Giannotta, Taub N, D'Cruz D, Hughes G. Environmental factors predicting the nephritis in SLE. Ann Rheum Dis 1993;52:720-4.
5. Petri M. Smoking is a risk factor for musculoskeletal, pulmonary, and cardiac disease in SLE [abstract]. Arthritis Rheum 1997;40 Suppl:S118.
6. Collins RL, Turner RA, Nomeir AM, et al. Cardiopulmonary manifestations of systemic lupus erythematosus. J Rheumatol 1978;5:299-306.
7. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997;15;100:3019-26.
8. Tebbe B, Orfanos CE. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997;6:96-104.
9. Strom BL, Reidenberg MM, West S, Snyder ES, Freundlich B, Stolley PD. Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol 1994;140:632-42.
10. Ghaussy NO, Sibbitt WL Jr, Qualls CR. Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: a case-control study. J Rheumatol 2001;28:2449-53.
11. Brown K, Petri M, Goldman D. Cutaneous manifestations of SLE: Associations with other manifestations of SLE and with smoking [abstract]. Arthritis Rheum 1995;38 Suppl:R27.
12. Rahman P, Gladmann DD, Urowitz MB. Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Rheumatol 1998;25;25:1716-9.
13. Nagata C, Fujita S, Iwata H, et al. SLE: A case controlled epidemiological study in Japan. Int J Dermatol 1995;34:333-7.
14. Hardy CJ, Palmer BP. Muir KR, Sutton AJ, Powell RJ. Smoking history, alcohol consumption, and systemic lupus erythematosus: a case controlled study. Ann Rheum Dis 1998;57:451-5.
15. Benoni A, Nilsson A, Nived O. Smoking and inflammatory bowel disease: Comparison with systemic lupus erythematosus: A case control study. Scand J Gastroenterol 1990;25:751-5.
16. McAlindon T, Felson D, Palmer J, Zheng L, Rosenberg L. Associations of cigarette smoking and alcohol with systemic lupus erythematosus among participants in the Black Women's Health Study [abstract]. Arthritis Rheum 1997;40 Suppl:S162.
17. Reidenberg MM, Drayer DE, Lorenzo B, et al. Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthritis Rheum 1993;36:971-3.
18. Petri M. Hopkins Lupus Cohort 1999 Update. Rheum Dis Clin N Am 2000;26:199-213.
19. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prongnosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
20. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for Systemic Lupus Erythematosus. Arthritis Rheum 1996;39:363-9.
21. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
22. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725-34.
23. Sacco RL. Newer risk factors for stroke. Neurology 2001;57 Supp 12:S31-4.
24. Herbert M, Foulds J, Fife-Schaw C. No effect of cigarette smoking on attention or mood in non-deprived smokers. Addiction 2001;96:1349-56.
25. Gonzalez-Pinto A, Gutierrez M, Ezcurra J, et al. Tobacco smoking and bipolar disorder. J Clin Psychiatry 1998;59:225-8.
26. Torelli P, Manzoni GC. What predicts evolution from episodic to chronic cluster headache? Curr Pain Headache Rep 2002;6:65-70.
27. Koren G. The association between maternal cigarette smoking and psychiatric diseases or criminal outcome in the offspring: a precautionary note about the assumption of causation. Reprod Toxicol 1999;13:345-6.
28. Cirillo M, Stellato D, Lombardi C, De Santo NG, Covelli V. Headache and cardiovascular risk factors: positive association with hypertension. Headache 1999 Jun;39:409-16.
29. Patten CA, Gillin JC, Golshan S, Wolter TD, Rapaport M, Kelsoe J. Relationship of mood disturbance to cigarette smoking status among 252 patients with a current mood disorder. J Clin Psychiatry 2001;62:319-24.
30. Dalack GW, Becks L, Hill E, Pomerleau OF, Meador-Woodruff JH. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology 1999;21:195-202.
31. SAS Institute Inc. SAS/STAT Software: Changes and enhancements through Release 6.11, Cary, NC: SAS Institute Inc.; 1996.
32. Uhlig T. Hagen KB, Kvien TK. Current tobacco smoking, formal education, and risk of rheumatoid arthritis. J Rheumatol 1999;26:1:47-54.
33. Voight LF, Koepsell TD, Nelson JL, Dugowson CE, Daling JR. Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology 1994;5:525-32.
34. Heliovaara M, Aho K, Aromaa A, Knekt P, Reunanen A. Smoking and risk of rheumatoid arthritis. J Rheumatol 1993;20:1830-5.
35. Hazes JMW, Dijkmans BAC, Vandenbroucke JP, P de Vries RR, Cats P. Lifestyle and the risk of rheumatoid arthritis cigarette smoking and alcohol consumption. Ann Rheum Dis 1990;49:980-2.
36. Karlson EW, Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 1999;42:910-7.
37. Saag KG, Cerhan JR, Kolluri S, Ohashi K, Hunninghake GW, Schwartz DA. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 1997;56:463-9.
38. Hernandez Avila M, Liang MH, Willett WC, et al. Reproductive factors, smoking, and the risk for rheumatoid arthritis. Epidemiology 1990;1:285-91.
39. Finette BA, O'Neill JP, Vacek PM, Albertini RJ. Gene mutations with characteristic deletions in cord blood T lymphocyte associated with passive maternal exposure to tobacco smoke. Nat Med 1998;4:1144-51.
40. Silman AJ, Newman J, MacGregor AJ. Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum 1996;39:732-5.
41. Wallace DJ. Principles of therapy and local measures. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus, 5th ed. Baltimore: William and Wilkins; 1997:1101.
42. Gegrge J, Levy Y, Shoenfeld Y. Smoking and immunity: an additional player in the mosaic of autoimmunity. Scand J Immunol 1997;45:1-6.
43. Mongey AB, Hess EV. The role of environment in SLE and associated disorders. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. 5th ed. Baltimore: Williams and Wilkins; 1997:31-2.
44. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-210.
45. Pyatt DW, Stillman WS, Irons RD. Hydroquinone, a reactive metabolite of benzene, inhibits NF-kappa B in primary human CD4+ T lymphocytes. Toxicol Appl Pharmacol 1998;149:178-84.
46. McKinnon RA, Nebert DW. Possible role of cytochromes P450 in lupus erythematosus and related disorders. Lupus 1994;3:473-8.
47. Yang Q, Hergenhahn M, Bartsch H. Epstein-Barr virus episomes as targets for cigarette smoke- and gamma-irradiation-induced DNA damage: studies on the EBNA-1 region by a new gene-specific technique. Carcinogenesis 1997;18:1401-5.
48. Muller T. Expression of c-fos in quiescent Swiss 3T3 cells exposed to aqueous cigarette smoke fractions. Cancer Res 1995;55:1927-32.
49. Suzuki N, Wakisaka S, Takeba Y, Mihara S, Sakane T. Effects of cigarette smoking on Fas/Fas ligand expression of human lymphocytes. Cell Immunol 1999;192:48-53.
50. Hirvonen A. Genetic factors in individual responses to environmental exposures. J Occup Environ Med 1995;37:37-43.
51. Reidenberg MM, Durant PJ, Harris RA, De Boccardo G, Lahita R, Stenzel KH. Lupus erythematosus-like disease due to hydrazine. Am J Med 1983;75:365-9.
52. Spector TD, Blake DR. Effect of cigarette smoking on Langerhans' cells. Lancet 1988;2:1028-9.
53. Scofield RH, James J. Immunization as a model for systemic lupus erythematosus. Arthritis Rheum 1999;29:140-7.
54. Holschermann H, Terhalle HM, Zakel U, et al. Monocyte tissue factor expression is enhanced in women who smoke and use oral contraceptives. Thromb Haemost 1999;82:1614-20.
55. Kaufman LD, Varje J. Cigarette smoking and other acquired risk factors for rheumatoid arthritis. In: Rheumatic diseases and the environment. London: Oxford University Press; 1999:111-29.
56. Klesges RC, Debon M, Ray JW. Are self-reports of smoking rate biased? Evidence from the Second National Health and Nutrition Examination Survey. J Clin Epidemiol 1995;48:1225-33.
57. Kim SY, Chung JH, Kang KW, Joe CO, Park KH. Relationship between activities of cytochrome P-450 monooxygenases in human placental microsomes and binding of benzo(a)pyrene metabolites to calf thymus DNA. Drug Chem Toxicol 1992;15:313-27.
58. Mooney LA, Perera FP, Van Bennekum AM, et al. Gender differences in autoantibodies to oxidative DNA base damage in cigarette smokers. Cancer Epidemiol Biomarkers Prev 2001;10:641-8.
59. Pulera N, Petruzzelli S, Celi A, et al. Presence and persistence of serum anti-benzo[a]pyrene diolepoxide-DNA adduct antibodies in smokers: effects of smoking reduction and cessation. Int J Cancer 1997;70:145-9.
60. Petitti DB, Friedman GD, Kahn W. Accuracy of information on smoking habits provided on self-administered research questionnaires. Am J Public Health 198;71:308-11.
61. Luepker RV, Pallonen UE, Murray DM, Pirie PL. Validity of telephone surveys in assessing cigarette smoking in young adults. Am J Public Health 1989;79:202-4.
62. Gladman DD, Goldsmith CH, Urowitz MB, et al. Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 1994;21:8:1468-71.